Study Finds Early And Delayed Stem Cell Transplants Have Comparable Efficacy ... The Myeloma Beacon Results of a recent analysis suggest that newly diagnosed multiple myeloma patients receiving Revlimid or thalidomide as initial therapy have similar prognoses regardless of whether they receive an early stem cell transplant or delay the transplant and ... |
